Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has…
Swiss-based biopharmaceutical drugmaker Debiopharm presented results for its novel IAP antagonist Debio 1143 from phase two trial, for high-risk Head and Neck cancer patients, which met its primary goal of increasing treatment efficacy compared to CRT and placebo.
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest market research engagement…
OXNARD, Calif.–(BUSINESS WIRE)–#cellandgene—Celavie Biosciences, LLC, a company working to improve lives and restore hope by advancing innovations in CNS diseases…
The Q-Codes will make the innovative soft-tissue regeneration products more accessible to the market at large PHOENIX–(BUSINESS WIRE)–#regenerativetherapies—BioLab Sciences, Inc.,…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…
TORONTO–(BUSINESS WIRE)–#FSDDF–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company“) is pleased to provide an update…
New rare disease therapy supported by AmerisourceBergen’s unified offerings including specialty pharmacy dispensing, distribution services, 3PL and community oncology services…
LineaRx Platform Used in Phase II trial in recurrent prostate cancer demonstrates the number of circulating tumor cells correlates more…
BaseCase platform can now perform live statistical modeling and sophisticated data analyses, delivering evidence-based claims to support value messages during…